Evaluating the emerging companies within the Organ-Chip Sector
What are the limitations of an organ-chips approach to research? Will their use increase the speed at which drugs will get to the clinical testing phase?
What are the limitations of an organ-chips approach to research? Will their use increase the speed at which drugs will get to the clinical testing phase?